Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Keyu Ren, Chunming Yong, Yanting Wang, Hongyun Wei, Kun Zhao, Baoguo He, Mingjuan Cui, Yunqing Chen & Jin Wang. (2023) Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations. Infection and Drug Resistance 16, pages 6195-6208.
Read now
Read now
Mikolaj Swierczynski, Adam Makaro, Agata Grochowska & Maciej Salaga. (2023) Pharmacological approaches to treat intestinal pain. Expert Review of Clinical Pharmacology 16:4, pages 297-311.
Read now
Read now
Tea Lamberg, Taina Sipponen, Sanna Valtanen, Kari K Eklund, Tarja Mälkönen, Kristiina Aalto, Katriina Mikola, Kaija-Leena Kolho, Sanna Leinonen, Pia Isomäki, Heidi Mäkinen, Krista-Liisa Vidqvist, Arto Kokko, Laura Huilaja, Minna Kyllönen, Paula Keskitalo, Sirja Sard, Paula Vähäsalo, Ritva Koskela, Liisa Kröger, Perttu Lahtinen, Anna-Maija Haapala, Katja Korkatti, Tuulikki Sokka-Isler & T. Sakari Jokiranta. (2022) Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases. Autoimmunity 55:5, pages 275-284.
Read now
Read now
Fengqian Chen, Qi Liu, Yang Xiong & Li Xu. (2021) Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. International Journal of Nanomedicine 16, pages 4225-4237.
Read now
Read now
Rovshan M. Ismailov, Lieven Pouillon, Christian P. Selinger & Zaytuna D. Khasanova. (2021) Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USA. Expert Opinion on Biological Therapy 21:1, pages 111-119.
Read now
Read now
Eleonora Allocati & Brian Godman. (2020) Key patient related factors in the management of inflammatory bowel disease. Journal of Medical Economics 23:12, pages 1606-1609.
Read now
Read now
Evelyn Walter, Sophie-Christin Hausberger, Evelyn Groß & Uwe Siebert. (2020) Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria. Journal of Medical Economics 23:10, pages 1061-1071.
Read now
Read now
Songmao Zheng, Jin Niu, Brian Geist, Damien Fink, Zhenhua Xu, Honghui Zhou & Weirong Wang. (2020) A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model. mAbs 12:1.
Read now
Read now
Ennio Lubrano, Silvia Scriffignano & Fabio Massimo Perrotta. (2019) TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis. Expert Review of Clinical Immunology 15:12, pages 1303-1312.
Read now
Read now
Laurent Peyrin-Biroulet, Silvio Danese, Fraser Cummings, Raja Atreya, Kay Greveson, Burkhard Pieper & Taegyun Kang. (2019) Anti-TNF biosimilars in Crohn’s Disease: a patient-centric interdisciplinary approach. Expert Review of Gastroenterology & Hepatology 13:8, pages 731-738.
Read now
Read now
Tagore Sunkara, Prashanth Rawla, Andrew Ofosu & Vinaya Gaduputi. (2018) Fecal microbiota transplant – a new frontier in inflammatory bowel disease. Journal of Inflammation Research 11, pages 321-328.
Read now
Read now
Articles from other publishers (78)
Emily C L Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch & Neeraj Narula. (2023) Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease. Inflammatory Bowel Diseases 29:7, pages 1015-1023.
Crossref
Crossref
Alexander S. BangMarwa HakimiPeggy TahirTina BhutaniKieron S. Leslie. (2023) Biologic Therapies in HIV/AIDS Patients with Inflammatory Diseases: A Systematic Review of the Literature. AIDS Patient Care and STDs 37:5, pages 215-242.
Crossref
Crossref
Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni, Melania Dovizio, Flavio Caprioli, Fernando Rizzello, Marco Daperno & Alessandro Armuzzi. (2023) Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting. Digestive and Liver Disease.
Crossref
Crossref
Maia Kayal, Ryan C. Ungaro, Geoffrey Bader, Jean-Frederic Colombel, William J. Sandborn & Carlos Stalgis. (2023) Net Remission Rates with Biologic Treatment in Crohn’s Disease: A Reappraisal of the Clinical Trial Data. Clinical Gastroenterology and Hepatology 21:5, pages 1348-1350.
Crossref
Crossref
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat & Cannanore Ganesh Pai. (2023) Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?. International Immunopharmacology 116, pages 109597.
Crossref
Crossref
Zixuan Bai, Jiewen Wang, Jiaqi Li, Haibin Yuan, Ping Wang, Miao Zhang, Yuanhang Feng, Xiangtong Cao, Xiangan Cao, Guangbo Kang, Ario de Marco & He Huang. (2023) Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations. Computational and Structural Biotechnology Journal 21, pages 601-613.
Crossref
Crossref
Azadeh Tabari, Jess L. Kaplan, Susanna Y. Huh, Christopher J. Moran & Michael S. Gee. (2022) Clinical characteristics and MRI-based phenotypes of perianal abscess formation in children with fistulizing Crohn's Disease. Frontiers in Pediatrics 10.
Crossref
Crossref
Hyun Jung Kim, Young-Ju Lee, Seon-Ok Back, Shin-Hyeong Cho, Hee-Il Lee & Myoung-Ro Lee. (2022) Treatment with Extracellular Vesicles from Giardia lamblia Alleviates Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice. The Korean Journal of Parasitology 60:5, pages 309-315.
Crossref
Crossref
Alix Démaris, Ella S. K. Widigson, Johan F. K. F. Ilvemark, Casper Steenholdt, Jakob B. Seidelin, Wilhelm Huisinga, Robin Michelet, Linda B. S. Aulin & Charlotte Kloft. (2022) Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review. Pharmaceutics 14:10, pages 2095.
Crossref
Crossref
Alan Menter, Stanley Cohen, Jonathan Kay, Vibeke Strand, Alice Gottlieb, Stephen Hanauer, Sravan Kumar Eduru, Susanne Buschke, Benjamin Lang, Karl-Heinz Liesenfeld, Jennifer Schaible & Dorothy McCabe. (2022) Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial. American Journal of Clinical Dermatology 23:5, pages 719-728.
Crossref
Crossref
Haosheng Shen, Nikhil Aggarwal, Kwok Soon Wun, Yung Seng Lee, In Young Hwang & Matthew Wook Chang. (2022) Engineered microbial systems for advanced drug delivery. Advanced Drug Delivery Reviews 187, pages 114364.
Crossref
Crossref
Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Maria Saeed, Baraa HajkhderMullaissa, Hassan Asiri, Abdullah Almutairi & Yazed AlRuthia. (2022) Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study. Journal of Clinical Medicine 11:14, pages 4157.
Crossref
Crossref
Neeraj Narula, Emily C.L. Wong, Parambir S. Dulai, Neil K. Sengupta, John K. Marshall, Jean-Frederic Colombel & Walter Reinisch. (2022) Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease. Clinical Gastroenterology and Hepatology 20:7, pages 1579-1587.e2.
Crossref
Crossref
Nilesh Kulkarni, Priti Jain, Amol Shindikar, Pravin Suryawanshi & Nanasaheb Thorat. (2022) Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease. Carbohydrate Polymers 288, pages 119351.
Crossref
Crossref
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras & Stergios A Polyzos. (2022) Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. Journal of Crohn's and Colitis 16:5, pages 852-862.
Crossref
Crossref
Hala Najeeb, Farah Yasmin & Salim Surani. (2022) Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients. World Journal of Clinical Cases 10:14, pages 4327-4333.
Crossref
Crossref
José R. Cruz-Muñoz, Tonatiuh Barrios-García, Eduardo E. Valdez-Morales, María F. Durán-Vazquez, Karen B. Méndez-Rodríguez, Alma Barajas-Espinosa, Fernando Ochoa-Cortes, María C. Martínez-Saldaña, Yenny A. Gómez-Aguirre & Raquel Guerrero Alba. (2022) Ethanolic extract from Lepidium virginicum L. ameliorates DNBS-induced colitis in rats. Journal of Ethnopharmacology 289, pages 115056.
Crossref
Crossref
Jialing Liu, Xingqiang Lai, Yingying Bao, Wenfeng Xie, Zhishan Li, Jieying Chen, Gang Li, Tao Wang, Weijun Huang, Yuanchen Ma, Jiahao Shi, Erming Zhao, Andy Peng Xiang, Qiuli Liu & Xiaoyong Chen. (2022) Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells. Frontiers in Immunology 13.
Crossref
Crossref
Nischay N. Shah, Sojin Wass, Jamal Hajjari, Andrew C. Heisler, Shahdi Malakooti, Scott E. Janus & Sadeer G. Al-Kindi. (2022) Proportionate Cardiovascular Mortality in Chronic Inflammatory Disease in Adults in the United States From 1999 to 2019. JCR: Journal of Clinical Rheumatology 28:2, pages 97-103.
Crossref
Crossref
Maheeba Abdulla, Jehad AlQamish, Nafeesa Mohammed, Mahmood Al Saeed, HasanJawad Al Aali, Aysha Al Khaja, ZahraAbdulla Isa Yusuf Hasan, FatemaYusuf Haider, SayedDhiyaa Noor Ebrahim, ZahraSayed Alawi Mahfoodh, MahmoodAli Hasan Hubail, Isa Alhajri, Fatema Al-Matrook & Ahmed Tork. (2022) Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience. Saudi Journal of Gastroenterology 28:3, pages 193.
Crossref
Crossref
Lynn Huynh, Steve Hass, Laurent Peyrin-Biroulet, Mei Sheng Duh, Heather Sipsma, Mu Cheng, Angie Lax & Arpita Nag. (2022) Real-World Treatment Patterns and Physician Preferences for Biologics in Moderate-to-Severe Inflammatory Bowel Disease: Retrospective Chart Review in Europe. Crohn's & Colitis 360 4:1.
Crossref
Crossref
Marina Cecelja & Phil Chowienczyk. 2022. Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease. Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease
795
806
.
Wenkang Gao, Zhonglin Li, Huikuan Chu, Hang Yuan, Lilin Hu, Lin Yao, Li Zhang, Weijun Wang, Rong Lin & Ling Yang. 2022. Pharmacotherapy for Liver Cirrhosis and Its Complications. Pharmacotherapy for Liver Cirrhosis and Its Complications
81
111
.
Jessica Amankwah Osei, Juan Nicolás Peña-Sánchez, Sharyle A Fowler, Nazeem Muhajarine, Gilaad G Kaplan & Lisa M Lix. (2021) Increasing Prevalence and Direct Health Care Cost of Inflammatory Bowel Disease Among Adults: A Population-Based Study From a Western Canadian Province. Journal of the Canadian Association of Gastroenterology 4:6, pages 296-305.
Crossref
Crossref
Laimas Jonaitis, Srdjan Marković, Klaudia Farkas, Liana Gheorghe, Željko Krznarić, Riina Salupere, Viktorija Mokricka, Zoya Spassova, Dimo Gatev, Isabella Grosu, Anton Lijović, Olga Mitrović, Mateja Saje, Eszter Schafer, Viktor Uršič, Tina Roblek & David Drobne. (2021) Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective. BMC Proceedings 15:S17.
Crossref
Crossref
Mariam Bqain, Alex Efimov, David Baker & Angray S. Kang. (2021) Immunogenicity of biologics used in the treatment of inflammatory bowel disease. Human Antibodies 29:4, pages 225-235.
Crossref
Crossref
Simcha Weissman, Kirtenkumar Patel, Sindhura Kolli, Megan Lipcsey, Nabeel Qureshi, Sameh Elias, Aaron Walfish, Arun Swaminath & Joseph D Feuerstein. (2021) Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden. Journal of Crohn's and Colitis 15:11, pages 1807-1815.
Crossref
Crossref
Anitha Sriram, Suma Tangirala, Srividya Atmakuri, Sajid Hoque, Sheela Modani, Saurabh Srivastava, Srushti Mahajan, Indrani Maji, Rahul Kumar, Dharmendra Khatri, Jitender Madan & Pankaj Kumar Singh. (2021) Budding Multi-matrix Technology—a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 22:8.
Crossref
Crossref
Brandon Dow Chan, Wing-Yan Wong, Magnolia Muk-Lan Lee, Tsz-Wing Leung, Tan-Yu Shum, William Chi-Shing Cho, Sibao Chen & William Chi-Shing Tai. (2021) Centipeda minima Extract Attenuates Dextran Sodium Sulfate-Induced Acute Colitis in Mice by Inhibiting Macrophage Activation and Monocyte Chemotaxis. Frontiers in Pharmacology 12.
Crossref
Crossref
Matthijs David Linssen, Wouter Tjerk Rudolph Hooghiemstra, Annelies Jorritsma-Smit, Derk Pieter Allersma, Gerard Dijkstra & Wouter Bastiaan Nagengast. (2021) Development and Characterisation of Antibody-Based Optical Imaging Probes for Inflammatory Bowel Disease. Pharmaceuticals 14:9, pages 922.
Crossref
Crossref
Mahnur Haider & Bret Lashner. (2021) Dual Targeted Therapy for the Management of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 55:8, pages 661-666.
Crossref
Crossref
D.C.R. Fernandes & H.J.N. Andreyev. (2021) Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?. Clinical Oncology 33:9, pages 591-601.
Crossref
Crossref
Nilesh Chande, Siddharth Singh, Neeraj Narula, Morris Gordon, M Ellen Kuenzig, Tran M Nguyen, John K MacDonald & Brian G Feagan. (2021) Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews. Inflammatory Bowel Diseases 27:9, pages 1513-1524.
Crossref
Crossref
Jose Antonio Quiros, Annie Lintzenich Andrews, Daniel Brinton, Kit Simpson & Annie Simpson. (2021) Insurance Type Influences Access to Biologics and Healthcare Utilization in Pediatric Crohn’s Disease. Crohn's & Colitis 360 3:3.
Crossref
Crossref
Michael J. Stewart, Talat Bessissow, James Gregor, Maureen Hazel, Tracy S. H. In, Kinda Karra, Dorota Dajnowiec, Martin Williamson & Bernie Sattin. (2021) Subcutaneously Administered Anti-TNFs for the Treatment of Ulcerative Colitis: A Retrospective, Propensity Score-Matched, US Health Claims Analysis. Advances in Therapy 38:7, pages 4115-4129.
Crossref
Crossref
Andra-Iulia Suceveanu, Andrada Dumitru, Marilena Musat, Claudia Voinea, Felix Voinea, Irinel Parepa, Anca Pantea Stoian, Laura Mazilu & Adrian Paul Suceveanu. 2021. Human Microbiome. Human Microbiome.
Anna Socha-Banasiak, Patrycja Sputa-Grzegrzółka, Jędrzej Grzegrzółka, Krzysztof Pacześ, Piotr Dzięgiel, Beata Sordyl, Hanna Romanowicz & Elżbieta Czkwianianc. (2021) Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-9.
Crossref
Crossref
Pepijn W. A. Thomas, Rachel L. West, Maurice G. V. M. Russel, Jeroen M. Jansen, Leanne J. Kosse, Naomi T. Jessurun, Tessa E. H. Römkens & Frank Hoentjen. (2020) Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system. Pharmacoepidemiology and Drug Safety 30:4, pages 520-524.
Crossref
Crossref
Matthew I. Bury, Natalie J. Fuller, Tristan D. Clemons, Renea M. Sturm, Christopher D. Morrison, Devon C. Lisy‐Snow, Bonnie G. Nolan, Christopher Tarczynski, Emily M. T. Ayello, Amber Boyce, Bridget Muckian, Nida Ahmad, Catherine J. Hunter, Mark R. Karver, Samuel I. Stupp & Arun K. Sharma. (2021) Self‐Assembling Nanofibers Inhibit Inflammation in a Murine Model of Crohn's‐Disease‐Like Ileitis. Advanced Therapeutics 4:4.
Crossref
Crossref
Tsen-Fang Tsai, Tsu-Yi Hsieh, Ching-Chi Chi, Chung-Tei Chou, Lin-Fen Hsieh, Hsin-Hua Chen, Rosaline Chung-Yee Hui, Chih-Hung Lee, Chin-Hsiu Liu, Hwa-Chang Liu, Kai-Jieh Yeo, Chun-Hsiung Chen, Hung-An Chen, Ying-Chou Chen, Yi-Ju Chen, Hsien-Yi Chiu, Ji-Chen Ho, Yu-Huei Huang, Po-Ju Lai, Woan-Ruoh Lee, Hsien-Tzung Liao, Shang-Hung Lin, Jui-Cheng Tseng, Ting-Shun Wang, Nan-Lin Wu, Deng-Ho Yang, Wen-Chan Tsai & James Cheng-Chung Wei. (2021) Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology. Journal of the Formosan Medical Association 120:3, pages 926-938.
Crossref
Crossref
Sendhilnathan Ramalingam & Ankoor Shah. (2021) Stem Cell Therapy as a Treatment for Autoimmune Disease—Updates in Lupus, Scleroderma, and Multiple Sclerosis. Current Allergy and Asthma Reports 21:3.
Crossref
Crossref
Abbasi A, Day S, Subahani M & Townson G. (2021) A Complex Case of Adalimumab Induced Pleuropericarditis in a Patient with Underlying Ulcerative Colitis. Asploro Journal of Biomedical and Clinical Case Reports 4:1, pages 16-21.
Crossref
Crossref
Ashira Blazer, Kinjan Parikh, David I. Fudman & Michael S. Garshick. 2021. Prevention and Treatment of Cardiovascular Disease. Prevention and Treatment of Cardiovascular Disease
179
191
.
Cindy C Y Law, Deborah Koh, Yueyang Bao, Vipul Jairath & Neeraj Narula. (2020) Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 26:12, pages 1796-1807.
Crossref
Crossref
Saurabh Talathi & Kondal R. Kyanam Kabir Baig. (2020) Biosimilars in inflammatory bowel disease. Journal of Digestive Diseases 21:11, pages 610-620.
Crossref
Crossref
Rangnath Mishra, Punita Dhawan, Anand S Srivastava & Amar B Singh. (2020) Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World Journal of Stem Cells 12:10, pages 1050-1066.
Crossref
Crossref
Cindy CY Law, Conor Bell, Deborah Koh, Yueyang Bao, Vipul Jairath & Neeraj Narula. (2020) Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Crossref
Bing Zhang, Alakh Gulati, Omeed Alipour & Ling Shao. (2020) Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 14:10, pages 1413-1423.
Crossref
Crossref
Xin Li, Chao Lu, Yanyan Yang, Chaohui Yu & Yuefeng Rao. (2020) Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease. Biomedicine & Pharmacotherapy 129, pages 110486.
Crossref
Crossref
Tyler McKechnie, Yung Lee, Colin Kruse, Karim Ramji, Jeremy E. Springer, Trevor Wood, Aristithes G. Doumouras, Dennis Hong & Cagla Eskicioglu. (2020) The role of fecal calprotectin in the diagnosis of acute pouchitis following IPAA for ulcerative colitis: a systematic clinical review. International Journal of Colorectal Disease 35:9, pages 1619-1628.
Crossref
Crossref
Artin Galoosian, Mona Rezapour, Benny Liu, Taft Bhuket & Robert J. Wong. (2020) Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States. Journal of Clinical Gastroenterology 54:7, pages e63-e72.
Crossref
Crossref
Konstantinos Gkikas, Konstantinos Gerasimidis, Simon Milling, Umer Z. Ijaz, Richard Hansen & Richard K. Russell. (2020) Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?. Nutrients 12:7, pages 2018.
Crossref
Crossref
Cynthia Morvillo, Katherine Vinci, Lauren Hedenschoug, Leah Mancini, Carrie Mize, Kayce Tugg & Steven Stein. (2020) Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease. Gastroenterology Nursing 43:4, pages E159-E171.
Crossref
Crossref
Brindusa Truta, Ira L Leeds, Joseph K Canner, Jonathan E Efron, Sandy H Fang, Azah Althumari & Bashar Safar. (2020) Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 26:7, pages 1110-1117.
Crossref
Crossref
Lydia Montes, Estelle Tredez, Clara Yzet, Caroline Delette, Denis Chatelain, Delphine Lebon, Mathurin Fumery & Jean‐Pierre Marolleau. (2020) Epstein‐Barr Virus‐related mucocutaneous ulcer lymphoma associated with Crohn's disease, treated with monoclonal antibody anti‐CD30. Clinical Case Reports 8:6, pages 958-961.
Crossref
Crossref
Tsvetelina Veselinova Velikova, Lyuba Miteva, Noyko Stanilov, Zoya Spassova & Spaska Angelova Stanilova. (2020) Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer. World Journal of Gastroenterology 26:16, pages 1912-1925.
Crossref
Crossref
Ieva Stundiene, Vaidota Maksimaityte, Valentina Liakina & Jonas Valantinas. (2020) Mucosa-associated lymphoid tissue lymphoma simulating Crohn’s disease: A case report. World Journal of Clinical Cases 8:8, pages 1454-1462.
Crossref
Crossref
Manuel O. Jakob, Shaira Murugan & Christoph S. N. Klose. (2020) Neuro-Immune Circuits Regulate Immune Responses in Tissues and Organ Homeostasis. Frontiers in Immunology 11.
Crossref
Crossref
HoUng Kim, Rieke Alten, Luisa Avedano, Axel Dignass, Fernando Gomollón, Kay Greveson, Jonas Halfvarson, Peter M. Irving, Jørgen Jahnsen, Péter L. Lakatos, JongHyuk Lee, Souzi Makri, Ben Parker, Laurent Peyrin-Biroulet, Stefan Schreiber, Steven Simoens, Rene Westhovens, Silvio Danese & Ji Hoon Jeong. (2020) The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs 80:2, pages 99-113.
Crossref
Crossref
Vibeke Strand, Joao Gonçalves, Timothy P. Hickling, Heather E. Jones, Lisa Marshall & John D. Isaacs. (2019) Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents. BioDrugs 34:1, pages 27-37.
Crossref
Crossref
Hongzhuan Xuan, Aiqun Ou, Shengyu Hao, Jiajun Shi & Xiaolu Jin. (2020) Galangin Protects against Symptoms of Dextran Sodium Sulfate-Induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota. Nutrients 12:2, pages 347.
Crossref
Crossref
Avni Jain, Ruth Ann Marrie, Leigh Anne Shafer, Lesley A Graff, Scott B Patten, Renée El-Gabalawy, Jitender Sareen, James M Bolton, John D Fisk & Charles N Bernstein. (2020) Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review. Crohn's & Colitis 360 2:1.
Crossref
Crossref
Hanh Nguyen & Ian Giles. 2020. Women's Health in Autoimmune Diseases. Women's Health in Autoimmune Diseases
77
92
.
Yazed AlRuthia, Othman Alharbi, Abdulrahman M. Aljebreen, Nahla A. Azzam, Majid A. Almadi, Ohud H. Bahari, Khalid A. Almalki, Abdulaziz T. Atham, Ahmed S. Alanazi, Maria Saeed, Baraa HajkhderMullaissa, Mohammad Alsenaidy & Bander Balkhi. (2019) Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia. Cost Effectiveness and Resource Allocation 17:1.
Crossref
Crossref
Yuki M.F. Andersen, Jashin J. Wu, Jacob P. Thyssen & Alexander Egeberg. (2019) Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis. Journal of the American Academy of Dermatology 81:6, pages 1283-1291.
Crossref
Crossref
Sara C. LaHue, Amy A. Gelfand & Riley M. Bove. (2019) Navigating monoclonal antibody use in breastfeeding women. Neurology 93:15, pages 668-672.
Crossref
Crossref
Iwona Krela-Kaźmierczak, Marzena Skrzypczak-Zielińska, Marta Kaczmarek-Ryś, Michał Michalak, Aleksandra Szymczak-Tomczak, Szymon T. Hryhorowicz, Marlena Szalata, Liliana Łykowska-Szuber, Piotr Eder, Kamila Stawczyk-Eder, Maciej Tomczak, Ryszard Słomski & Agnieszka Dobrowolska. (2019) ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s Disease. Journal of Clinical Medicine 8:9, pages 1306.
Crossref
Crossref
Christopher Ma, Robert Battat, Parambir S. Dulai, Claire E. Parker, William J. Sandborn, Brian G. Feagan & Vipul Jairath. (2019) Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs 79:12, pages 1321-1335.
Crossref
Crossref
Sulemon Chaudhry, Jean Emond & Adam Griesemer. (2019) Immune Cell Trafficking to the Liver. Transplantation 103:7, pages 1323-1337.
Crossref
Crossref
Haridarshan Patel, Dominick Latremouille-Viau, Rebecca Burne, Sherry Shi & Shashi Adsul. (2019) Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 1:2.
Crossref
Crossref
Mario Montoya Jaramillo, Felipe Herrera Ruiz, Edgar Eliud Castillo, Alexander Pabón Moreno, Neylor Chalabe Jimenez, Víctor Leal Martínez, Jeison Torrens Soto & Leonardo Fontecha Gomez. (2019) Síndrome de Guillain-Barré asociado al uso de Adalimumab en un paciente con colitis ulcerosa. A propósito de un caso. Acta Colombiana de Cuidado Intensivo 19:2, pages 117-121.
Crossref
Crossref
Andreea Aprodu, Julia Mantaj, Bahijja Raimi-Abraham & Driton Vllasaliu. (2019) Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics 11:3, pages 127.
Crossref
Crossref
Shahnaz Khan, Ewa Rupniewska, Mackenzie Neighbors, David Singer, Joseph Chiarappa & Camilo Obando. (2019) Real‐world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Pan Xu, Elhaseen Elamin, Montserrat Elizalde, Paul P. H. A. Bours, Marieke J. Pierik, Ad A. M. Masclee & Daisy M. A. E. Jonkers. (2019) Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model. Scientific Reports 9:1.
Crossref
Crossref
Cindy CY Law, Deborah Koh, Yueyang Bao, Vipul Jairath & Neeraj Narula. (2019) Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Caroline M. Percopo, Michelle Ma, Todd A. Brenner, Julia O. Krumholz, Timothy J. Break, Karen Laky & Helene F. Rosenberg. (2019) Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection. The Journal of Immunology 202:3, pages 871-882.
Crossref
Crossref
Amosy M’Koma. (2018) The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointestinal Disorders 1:1, pages 75-105.
Crossref
Crossref
Joanna Sieczkowska-Golub, Dorota Jarzebicka, Grzegorz Oracz & Jaroslaw Kierkus. (2018) Biosimilars in paediatric inflammatory bowel disease. World Journal of Gastroenterology 24:35, pages 4021-4027.
Crossref
Crossref